New York-based JLL Partners has sold its drug development services company PharmaNet Development Group. Financial terms of the deal have not been disclosed.
inVentiv Health, a unit of Thomas H Lee Partners, has bought the firm. JLL, a private equity investment firm with nearly $4 billion under management, purchased PharmaNet in 2009.
Click here for the release from PR Newswire.